Publication:
Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard

Simple item page
dc.contributor.coauthorYalman, Deniz
dc.contributor.departmentN/A
dc.contributor.kuauthorSelek, Uğur
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid27211
dc.date.accessioned2024-11-09T23:36:42Z
dc.date.issued2015
dc.description.abstractN/A
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue11
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.volume3
dc.identifier.doi10.3978/j.issn.2305-5839.2015.06.23
dc.identifier.eissn2305-5847
dc.identifier.issn2305-5839
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85015483458
dc.identifier.urihttp://dx.doi.org/10.3978/j.issn.2305-5839.2015.06.23
dc.identifier.urihttps://hdl.handle.net/20.500.14288/12692
dc.identifier.wos218801500003
dc.keywordsN/A
dc.languageEnglish
dc.publisherAme Publ Co
dc.sourceAnnals of Translational Medicine
dc.subjectOncology
dc.subjectMedicine
dc.subjectMedicine, Experimental
dc.titleStereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard
dc.typeOther
dc.type.otherEditorial material
dspace.entity.typePublication
local.contributor.authorid0000-0001-8087-3140
local.contributor.kuauthorSelek, Uğur

Files

Collections

Publications without Fulltext